期刊文献+

化疗相关心脏毒性问题研究进展 被引量:3

Advances on chemotherapy-related cardiotoxicity
下载PDF
导出
摘要 化疗作为肿瘤治疗手段的基石之一,可引起心力衰竭、冠脉病变、瓣膜病、心律失常等心脏毒性事件,其相关近期、远期心脏毒性问题均需受到临床医生重视。近年来随着肿瘤心脏病学交叉学科的发展,化疗药物相关心肌损伤问题在病理生理机制、诊断、治疗等方面均取得了一定进展,但仍然存在诸多问题。该综述从不同化疗药物引起心血管事件的流行病学、临床特点、机制、诊断及治疗策略方面简要介绍其心脏毒性的诊治问题,为临床实践提供参考。 As one of the cornerstones of tumor therapies,chemotherapy can cause heart failure,coronary artery disease,valvular disease,arrhythmia and so on.Its related acute and long cardiotoxicity need to be paid attention by clinicians.With the development of interdisciplinary oncology cardiology in recent years,progresses have been made in mechanism,diagnosis and treatment of chemotherapy-related myocardial injury,but there are still many problems that need to be solved.This review briefly introduces the diagnosis and treatment of cardiotoxicity from the aspects of epidemiology,clinical characteristics,mechanism research,diagnosis and treatment strategy of cardiovascular events caused by chemotherapy,so as to provide reference for clinical practice.
作者 苏毅馨 朱世杰 高业博 薛鹏 褚雪镭 谢飞宇 于成凤 张鑫 SU Yixin;ZHU Shijie;GAO Yebo;XUE Peng;CHU Xuelei;XIE Feiyu;YU Chengfeng;ZHANG Xin(Wangjing Hospital of China Academy of Chinese Medical Sciences,Beijing 100102,China;Beijing University of Chinese Medicine,Beijing 100029,China)
出处 《现代肿瘤医学》 CAS 北大核心 2022年第17期3253-3256,共4页 Journal of Modern Oncology
基金 北京市自然科学基金资助(编号:7204332)。
关键词 化疗 心脏毒性 研究进展 chemotherapy cardiotoxicity advances
  • 相关文献

参考文献2

二级参考文献50

  • 1张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 2姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 3Cvetkovi'c RS,Scott LJ.Dexrazoxane:a review of its use for cardioprotection during anthracycline chemotherapy[J].Drugs,2005,65(7):1005-1024.
  • 4Barry E,Alvarez JA,Scully RE,et al.Anthracycline-induced cardiotoxicity:course,pathophysiology,prevention and management[J].Expert Opin Pharmacother,2007,8 (8):1039-1058.
  • 5Lipshultz SE,Lipsitz SR,Sallan SE,et al.Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia[J].J Clin Oncol,2005,23(12):2629-2636.
  • 6Lipshultz SE,Colan SD,Gelber RD,et al.Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood[J].N EnglJ Med,1991,324(12):808-815.
  • 7Von Hoff DD,Layard MW,Basa P,et al.Risk factors for doxorubicin-induced congestive heart failure[J].Ann Intern Med,1979,91(5):710-717.
  • 8Swain SM,Whaley FS,Ewer MS,et al.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials[J].Cancer,2003,97 (11):2869-2879.
  • 9Keefe DL.Anthracycline-induced cardiomyopathy[J].Semin Oncol,2001,28(4 Suppl 12):2-7.
  • 10Ganame J,Claus P,Uyttebroeck A,et al.Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients[J].J Am Soc Echocardiogr,2007,20 (12):1351-1358.

共引文献3630

同被引文献54

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部